Janjua Nazli, Bulic Sebina, Tan Benedict C, Panichpisal Kessarin, Miller John
Asia Pacific Comprehensive Stroke Institute, Claremont, California, USA.
BMJ Case Rep. 2013 Mar 27;2013:bcr2012010535. doi: 10.1136/bcr-2012-010535.
Small aneurysms may be challenging to embolize. In cases of subarachnoid hemorrhage (SAH) where treatment is delayed, physicians may have to balance the risks of certain required therapies (antiplatelet agents) with the risk of rerupture. We describe a case of a technically challenging anterior cerebral artery aneurysm requiring eptifibatide infusion prior to definitive aneurysm treatment.
A 57-year-old woman with SAH, underwent coil embolization of a small fenestrated A1-A2 junction aneurysm. The procedure was complicated by downstream coil migration which was then treated with Enterprise stent placement in the pericallosal artery. This required subsequent infusion of a glycoprotein IIb/IIIa inhibitor until the aneurysm could be repaired surgically.
Revascularization with a stent in a distal cerebral vessel may salvage inadvertent coil migration. Although it is undesirable to administer antiplatelet agents to patients with SAH, in these circumstances short acting agents may be used.
小型动脉瘤的栓塞治疗可能具有挑战性。在蛛网膜下腔出血(SAH)治疗延迟的情况下,医生可能需要权衡某些必要治疗(抗血小板药物)的风险与再破裂风险。我们描述了一例技术上具有挑战性的大脑前动脉动脉瘤病例,在进行确定性动脉瘤治疗之前需要输注依替巴肽。
一名57岁的SAH女性患者,接受了小型开窗型A1 - A2交界处动脉瘤的弹簧圈栓塞治疗。该手术因弹簧圈下游移位而变得复杂,随后通过在胼周动脉置入Enterprise支架进行治疗。这需要随后输注糖蛋白IIb/IIIa抑制剂,直到可以通过手术修复动脉瘤。
在大脑远端血管中使用支架进行血管重建可能挽救意外的弹簧圈移位。虽然对SAH患者使用抗血小板药物是不可取的,但在这些情况下可使用短效药物。